China SXT Pharmaceuticals Inc (SXTC)
1.09
-0.02
(-1.80%)
USD |
NASDAQ |
Jun 28, 16:00
1.08
-0.01
(-0.92%)
After-Hours: 20:00
China SXT Pharmaceuticals Revenue (Annual): 1.972M for March 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| March 31, 2023 | 1.972M |
| March 31, 2022 | 2.602M |
| March 31, 2021 | 4.778M |
| March 31, 2020 | 5.162M |
| Date | Value |
|---|---|
| March 31, 2019 | 7.012M |
| March 31, 2018 | 7.019M |
| March 31, 2017 | 4.882M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.972M
Minimum
2023
5.162M
Maximum
2020
3.628M
Average
3.690M
Median
Revenue (Annual) Benchmarks
| Sinovac Biotech Ltd | 448.27M |
| CASI Pharmaceuticals Inc | 33.88M |
| Zai Lab Ltd | 266.72M |
| Adagene Inc | 18.11M |
| LakeShore Biopharma Co Ltd | 100.37M |